HealthEquity (NASDAQ:HQY – Get Free Report) updated its FY 2027 earnings guidance on Thursday. The company provided EPS guidance of 2.880-2.950 for the period, compared to the consensus EPS estimate of 4.470. The company issued revenue guidance of -.
Analyst Ratings Changes
Several equities analysts recently weighed in on the stock. JPMorgan Chase & Co. cut their price objective on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a report on Wednesday, March 18th. BMO Capital Markets raised HealthEquity from a “market perform” rating to an “outperform” rating and increased their price target for the company from $85.00 to $105.00 in a research note on Thursday, April 9th. UBS Group set a $110.00 price target on HealthEquity in a research note on Tuesday, February 17th. Royal Bank Of Canada dropped their price objective on HealthEquity from $110.00 to $100.00 and set an “outperform” rating for the company in a report on Wednesday, March 18th. Finally, Barclays dropped their price objective on HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a report on Wednesday, February 18th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $111.79.
View Our Latest Report on HealthEquity
HealthEquity Trading Up 4.6%
HealthEquity (NASDAQ:HQY – Get Free Report) last posted its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.13. The company had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities analysts predict that HealthEquity will post 3.84 earnings per share for the current year.
Institutional Investors Weigh In On HealthEquity
Several hedge funds have recently bought and sold shares of the company. Corient Private Wealth LLC acquired a new stake in HealthEquity in the fourth quarter worth $219,000. Pacer Advisors Inc. raised its holdings in HealthEquity by 16.9% in the fourth quarter. Pacer Advisors Inc. now owns 13,427 shares of the company’s stock worth $1,230,000 after purchasing an additional 1,937 shares during the period. Virtu Financial LLC acquired a new stake in HealthEquity in the fourth quarter worth $325,000. EP Wealth Advisors LLC acquired a new stake in HealthEquity in the fourth quarter worth $472,000. Finally, XTX Topco Ltd acquired a new stake in HealthEquity in the fourth quarter worth $289,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.
About HealthEquity
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Featured Articles
- Five stocks we like better than HealthEquity
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
